Artículos de revistas
Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine - Case report
Registro en:
Arquivos De Neuro-psiquiatria. Assoc Arquivos De Neuro- Psiquiatria, v. 57, n. 3B, n. 863, n. 866, 1999.
0004-282X
WOS:000083027600021
10.1590/S0004-282X1999000500021
Autor
Etchebehere, ECSC
Lima, MCL
Passos, W
Maciel, JA
Santos, AO
Ramos, CD
Camargo, EE
Institución
Resumen
Olanzapine, an atypical antipsychotic drug, was administered to a patient with Huntington's disease (HD) with marked choreiform movements. Brain SPECT with Tc-99m-HMPAO was performed before and after treatment. Brain SPECT imaging has been performed in patients with HD in order to determine the status of basal ganglia perfusion. The use of brain SPECT with Tc-99m-HMPAO before and after treatment in patients with HD has not been yet reported. The marked hypoperfusion of the basal ganglia on brain SPECT performed before therapy with olanzapine improved significantly after treatment. 57 3B 863 866